Jianping Zhang
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 8
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 6
- Immunology top 10%
- Oncology top 10%
- CAR-T cell therapy research 4
- Hepatology top 10%
-
- Thyroid Disorders and Treatments 4
- Pituitary Gland Disorders and Treatments 3
-
- Acute Lymphoblastic Leukemia research 5
-
- Pharmacological Effects and Toxicity Studies 4
- Cited by
- HematologyImmunologyOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jianping Zhang
64 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Hematology 209
- Immunology 364
- Oncology 427
- Hepatology 100
- Endocrinology, Diabetes and Metabolism 159
Countries citing papers authored by Jianping Zhang
This map shows the geographic impact of Jianping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Zhang more than expected).
Fields of papers citing papers by Jianping Zhang
This network shows the impact of papers produced by Jianping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Zhang. The network helps show where Jianping Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianping Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 7 | |
| 7 | 2020 | 32 | |
| 8 | Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapybreakdown → | 2019 | 488 |
| 9 | 2018 | 54 | |
| 10 | 2018 | 16 | |
| 11 | 2015 | 28 | |
| 12 | 2014 | 6 | |
| 13 | 2013 | 32 | |
| 14 | 2013 | 10 | |
| 15 | 2010 | 75 | |
| 16 | 2010 | 32 | |
| 17 | 2008 | 30 | |
| 18 | 2003 | 80 | |
| 19 | 2002 | 15 | |
| 20 | 1995 | 42 |
About Jianping Zhang
Jianping Zhang is a scholar working on Hematology, Geriatrics and Gerontology and Clinical Biochemistry, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Platelet Disorders and Treatments (7 papers), Blood groups and transfusion (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Thyroid Disorders and Treatments (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), CAR-T cell therapy research (4 papers) and Pituitary Gland Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (209 citations), Immunology (364 citations) and Oncology (427 citations). Jianping Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lieping Chen, Xinxin Nie, Jingwei Sun, Melissa Zarr, Kristina A. Archer, Chang Song, Xu Zhou, Xue Han, Jun Wang and Miguel F. Sanmamed. Their work appears in journals such as Nature Medicine, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.